28.04.2013
- A proposed merger of Valeant Pharmaceuticals International and Actavis was put on hold after the two drugmakers failed to agree on terms of a deal that would have created a...
02.04.2013
- Neurological and dermatology drugs maker Merz Pharma offered to buy cosmetic products maker Obagi Medical Products for $383.5 million, topping a bid by Canada's Valeant...
28.02.2013
- Valeant Pharmaceuticals International is in talks to make more acquisitions, its chief executive said on Thursday, adding that Canada's largest publicly traded drugmaker also...
31.01.2013
- Endo Health Solutions has held talks in recent weeks with drugmakers potentially interested in buying the maker of pain relief medication, people familiar with the matter said on...
17.11.2012
- The U.S. Federal Trade Commission has cleared Valeant Pharmaceuticals International's $2.6 billion deal to buy U.S. dermatology rival Medicis Pharmaceutical, without conditions...
04.09.2012
- Valeant Pharmaceuticals International agreed on Monday to buy Medicis Pharmaceutical for $2.6 billion in cash, in a deal that will add Botox competitor Dysport and other skin care...
30.01.2012
- Valeant Pharmaceuticals International said on Monday it has withdrawn its sweetened takeover bid for ISTA Pharmaceuticals, citing a lack of progress. "We were not interested in...
04.05.2011
- Valeant Pharmaceuticals, which dropped a $5.7 billion offer for Cephalon earlier this week, will actively pursue other large takeover deals, its chief executive said on Tuesday...
